Dr. Paul Bunn and C-Change
Accelerate
Nation’s Fight Against Cancer
 |
| Paul Bunn, Jr., MD |
C-Change, the first organization to bring together the public, private and
nonprofit sectors to address cancer as a societal problem has announced its
historic collaboration and its goal to prevent an additional one million new
cancer cases and 500,000 cancer deaths by 2010.
Paul A. Bunn, Jr., MD, director of the University
of Colorado Cancer Center is a member of C-Change, which is led by former
President George Bush, former First Lady Barbara Bush and U.S. Senator Dianne
Feinstein.
“Never before has the entire cancer community come together to accelerate
progress against this disease,” said President Bush. “C-Change
wants to streamline this nation’s efforts to save lives and eliminate
suffering from cancer. That is something I am proud to be a part of.”
Through participation in C-Change, Dr. Bunn joins 150 nationally recognized
leaders from across the cancer community to provide a united, multi-disciplinary
attack on cancer.
C-Change members include leaders
from:
Governmental
agencies with federal funding devoted to cancer research and/or applications
(including National Cancer Institute and the Centers for Disease Control and
Prevention)
Academic
cancer centers (including Howard University Cancer Center, Duke University
Cancer Center, Johns Hopkins, and many more)
Private,
for-profit companies (including Bristol-Myers Squibb, Glaxo Smith Kline, Chiron
Corporation and Johnson & Johnson Co.)
Nonprofit
advocacy/consumer organizations (including Breast Cancer Resource Committee,
Inc., National Patient Advocate Foundation, American Cancer Society, American
Legacy Foundation, Pancreatic Cancer Action Network)
Professional
organizations representing groups of individuals and/or organizations with
a common interest in cancer (including American Society of Clinical Oncology,
Oncology Nursing Society and American Association for Cancer Research)
Congressional,
administration, and state government officials (including West Virginia Governor
Bob Wise, as well as the directors of the NCI and CDC)
The
media (including Paula Zahn, Larry King and Sam Donaldson)
This truly historic collaboration marks the first time these diverse groups
representing all sectors of the cancer community have assembled to collectively
advance progress in key areas of cancer care. Through its collaborative power,
this unique public/private partnership intends to accelerate improvements
in cancer prevention, early detection, research, tobacco control and access
to care that cannot be achieved through individual efforts.
To do this, C-Change has assembled
seven
teams focused on the following areas:
Primary
Prevention and Early Detection
Cancer
Research
State
Cancer Plans
Access
to Quality Care
Clinical
Trials
Cancer
Workforce Study Group
Taskforce
on State Tobacco Funding
Dr. Bunn will serve on the Clinical Trials Team in the next year. These teams
are tackling such important issues as supporting the states in their efforts
to eliminate tobacco use, decreasing cancer disparities, increasing participation
in research studies, advancing research of new, innovative cancer treatments,
reaching underserved communities with information about screening and prevention
and bolstering the number of employees working to provide care to cancer patients.
In addition, Dr. Bunn will attend two meetings of the full C-Change membership
to discuss key issues and report on accomplishments.
Return to Vivat Online Front Page
